Your browser doesn't support javascript.
loading
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki, Koji; Kanagal-Shamanna, Rashmi; Montalban-Bravo, Guillermo; Assi, Rita; Jabbour, Elias; Ravandi, Farhad; Kadia, Tapan; Pierce, Sherry; Takahashi, Koichi; Nogueras Gonzalez, Graciela; Patel, Keyur; Soltysiak, Kelly A; Cortes, Jorge; Kantarjian, Hagop M; Garcia-Manero, Guillermo.
Afiliação
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kanagal-Shamanna R; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Montalban-Bravo G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Assi R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravandi F; Division of Hematology-Oncology, Lebanese American University and Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nogueras Gonzalez G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Soltysiak KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cortes J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 126(4): 765-774, 2020 02 15.
Article em En | MEDLINE | ID: mdl-31742675

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Leucemia Mieloide / Predisposição Genética para Doença / Mutação Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Leucemia Mieloide / Predisposição Genética para Doença / Mutação Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos